receptors, opioid, mu

Preferred Label : receptors, opioid, mu;

MeSH definition : A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.;

MeSH synonym : mu receptor; opioid receptors, mu; mu opioid receptors; receptors, mu opioid; receptors, mu; receptor, mu; mu receptors; mu opioid receptor; opioid receptor, mu; receptor, mu opioid;

Wikipedia automatic translation : Opioid receptor;

MeSH hyponym : morphine receptor; Receptor, Morphine; Receptors, Morphine; Morphine Receptors;

MeSH annotation : opioid receptors found in the hypothalamus; DF: RECEPT MU;

Wikipedia link : https://en.wikipedia.org/wiki/Opioid receptor;

Is substance : O;

Details

Origin ID

D017450;

UMLS CUI

C0066908;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- physiology [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Mu-Type Opioid Receptor [NCIt concept]
- Opioid receptor, mu-1 [OMIM gene]
- Receptor [UMLS semantic type]
- Receptor [NCIt concept]
- Receptor (substance) [SNOMED CT concept]
- receptor [IUPAC Term]
Indexing information
- (N-allyl-Dmt(1))endomorphin-2 [MeSH Supplementary Concept]
- 1,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamido)hexane [MeSH Supplementary Concept]
- 1-(10-((E)-3-phenyl-allyl)-3,10-diaza-bicyclo(4.3.1)dec-3-yl)propan-1-one [MeSH Supplementary Concept]
- 1-(N-cyclobutylmethylmorphinan-3-yl)-10-(N-cyclobutylmethylmorphinan-3-yl)sebacolyate [MeSH Supplementary Concept]
- 14-benzyloxy-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-one [MeSH Supplementary Concept]
- 17,17'-bis(cyclopropylmethyl)-6,6',7,7'-tetrahydro-4,5-4',5'-diepoxy-6,6'-(benzylimino)(7,7'-bimorphinan)-3,3',14,14'-tetrol [MeSH Supplementary Concept]
- 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-((3'-isoquinolyl)acetamido)morphinan [MeSH Supplementary Concept]
- 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-((4'-(3'-methylpyridyl))carboxamido)morphinan [MeSH Supplementary Concept]
- 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-((4'-pyridyl)acetamido)morphinan [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl--1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-psi(CH2MH)-phenylalanyl-phenylalaninamide [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalaninamide [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carbonyl-glycine N-benzylamide [MeSH Supplementary Concept]
- 2-amino-N-(6-benzyl-1,2,3,4-tetrahydroquinolin-4-yl)-3-(4-hydroxy-2,6-dimethylphenyl)propanamide [MeSH Supplementary Concept]
- 3,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamidopropyl)-2(1H)-pyrazinone [MeSH Supplementary Concept]
- 3-(2-dimethylaminomethylcyclohexyl)phenol [MeSH Supplementary Concept]
- 3-(7,8-dimethyl-2-(2-chlorobenzyl)octahydro-1H-pyrido(1,2-a)pyrazin-8-yl)phenol [MeSH Supplementary Concept]
- 3-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(4-fluorophenyl)-N-methylbenzamide [MeSH Supplementary Concept]
- 3-deoxyclocinnamox [MeSH Supplementary Concept]
- 4-tyrosylamido-6-benzyl-1,2,3,4 tetrahydroquinoline [MeSH Supplementary Concept]
- 4a,9-dihydroxy-7a-(hydroxymethyl)-3-methyl-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinolin-7(7aH)-one [MeSH Supplementary Concept]
- 5'-(4-chlorophenyl)-17-(cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3-hydroxy-14-(3-phenylpropoxy)pyrido(2',3'-6,7)morphinan [MeSH Supplementary Concept]
- 5'-(4-chlorophenyl)-6,7-didehydro-4,5alpha-epoxy-3-hydroxy-17-methylpyrido(2',3'-6,7)morphinan [MeSH Supplementary Concept]
- 5-(3-hydroxyphenyl)-2-phenethyl-2-azabicyclo(3.3.1)nonan-4-ol [MeSH Supplementary Concept]
- 5-methyl-14-(4-chlorocinnamoylamino)-7,8-dihydromorphinone [MeSH Supplementary Concept]
- 6-desoxymorphine [MeSH Supplementary Concept]
- 9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho(2,1-c)pyran-7-carboxylic acid methyl ester [MeSH Supplementary Concept]
- 9-hydroxy-5-(3-hydroxyphenyl)-2-phenylethyl-2-azabicyclo(3.3.1)nonane [MeSH Supplementary Concept]
- Dmt-NMe-Ala-Aba-Gly-NH2 [MeSH Supplementary Concept]
- JOM 6 [MeSH Supplementary Concept]
- KNT 93 [MeSH Supplementary Concept]
- N(1)-(2',6'-dimethyltyrosyl-arginyl-phenylalanyl-lysyl)-N(2)-(tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-psi(CH2NH)-cyclohexylalanyl-phenylalanyl)ethylenediamine [MeSH Supplementary Concept]
- N-((3,5-difluoro-3'-(1H-1,2,4-triazol-3-yl)-4-biphenylyl)methyl)-2,3-dihydro-1H-inden-2-amine [MeSH Supplementary Concept]
- N-cyclopropylmethyl-5-methyl-14-(4-chlorocinnamoylamino)-7,8-dihydronormorphinone [MeSH Supplementary Concept]
- N-ethyl-4-((8-phenethyl-8-azabicyclo(3.2.1)oct-3-ylidene)phenylmethyl)benzamide [MeSH Supplementary Concept]
- N-naphthoyl-beta-naltrexamine [MeSH Supplementary Concept]
- RV-Jim-C3 [MeSH Supplementary Concept]
- TRIMU 5 [MeSH Supplementary Concept]
- Tapentadol [MeSH Descriptor]
- alvimopan [MeSH Supplementary Concept]
- beta-casomorphins [MeSH Supplementary Concept]
- bis(N-cyclobutylmethylmorphinan)fumarate [MeSH Supplementary Concept]
- bis(N-cyclobutylmethylmorphinan)fumarate [MeSH Supplementary Concept]
- bis(N-cyclobutylmethylmorphinan-3-yl) sebacoylate dihydrochloride [MeSH Supplementary Concept]
- connective tissue-activating peptide [MeSH Supplementary Concept]
- cyclo(prolyl-1-naphthylalanyl-tryptophyl-tyrosyl-threonyl-phenylalanyl) [MeSH Supplementary Concept]
- cyclo(tyrosyl-prolyl-tryptophyl-phenylalanyl-glycyl) [MeSH Supplementary Concept]
- eluxadoline [MeSH Supplementary Concept]
- endomorphin 1 [MeSH Supplementary Concept]
- endomorphin 2 [MeSH Supplementary Concept]
- endomorphin-1, Dmt(1)-2-Nal(4)- [MeSH Supplementary Concept]
- endomorphin-2, 1-Nal(4)- [MeSH Supplementary Concept]
- endomorphin-2, Dmt(1)-2-Nal(4)- [MeSH Supplementary Concept]
- eribis peptide 94 [MeSH Supplementary Concept]
- methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate [MeSH Supplementary Concept]
- methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate [MeSH Supplementary Concept]
- mitragynine [MeSH Supplementary Concept]
- morphiceptin, Dmt(1)-Ala(2)-1-Nal(3)- [MeSH Supplementary Concept]
- morphiceptin, Dmt(1)-NMeAla(2)-1-Nal(3)- [MeSH Supplementary Concept]
- phenylalanyl-cysteinyl-tryptophyl-arginyl-threonyl-penicillamine-threoninamide [MeSH Supplementary Concept]
- phenylethyl orvinol [MeSH Supplementary Concept]
- tyrosyl-1,2,3,4-tetrahydro--3-isoquinolinecarbonyl-phenylalanyl-phenylalaninamide [MeSH Supplementary Concept]
- tyrosyl-alanyl-glycyl-phenylalanyl-methionyl-prolyl-leucyl-tryptophyl-O-3,5-benzyl(CF3)2 [MeSH Supplementary Concept]
- tyrosyl-alanyl-glycyl-phenylalanyl-norleucyl-prolyl-leucyl-tryptophyl-O-3,5-benzyl(CF3)2 [MeSH Supplementary Concept]
- tyrosyl-alanyl-glycyl-tryptophyl-N-methylnorleucyl-aspartyl-phenylalaninamide [MeSH Supplementary Concept]
- tyrosyl-alanyl-phenylalanyl-phenylalaninamide [MeSH Supplementary Concept]
- tyrosyl-arginyl-phenylalanyl-lysinamide [MeSH Supplementary Concept]
- tyrosyl-cyclo(allylglycyl-phenylalanyl-allylglycyl)amide [MeSH Supplementary Concept]
- tyrosyl-cyclo(lysyl-phenylalanyl-alanyl) [MeSH Supplementary Concept]
- tyrosyl-norleucyl-glycyl-tryptophyl-norleucyl-aspartyl-phenylalaninamide [MeSH Supplementary Concept]
- tyrosyl-ornithyl-phenylalanyl-glycine [MeSH Supplementary Concept]
- tyrosyl-phenylalanyl-glycyl-tryptophyl-N-methylnorleucyl-aspartyl-phenylalaninamide [MeSH Supplementary Concept]
Record concept(s)
- morphine receptor [MeSH concept]
- receptors, opioid, mu [MeSH concept]
Related MeSH Supplementary Concept(s)
- OPRM1 protein, human [MeSH Supplementary Concept]
- Oprm1 protein, rat [MeSH Supplementary Concept]
- PKCI protein, mouse [MeSH Supplementary Concept]
- dermorphin receptor [MeSH Supplementary Concept]
- dihydromorphine receptor [MeSH Supplementary Concept]
- oprm protein, mouse [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients